CDOR yields 4933.11% · ABBV yields 3.06%● Live data
📍 CDOR pulled ahead of the other in Year 1
Combined, CDOR + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CDOR + ABBV for your $10,000?
"C"o"n"d"o"r" "H"o"s"p"i"t"a"l"i"t"y" "T"r"u"s"t"," "I"n"c"." "("N"Y"S"E" "A"m"e"r"i"c"a"n":" "C"D"O"R")" "i"s" "a" "s"e"l"f"-"a"d"m"i"n"i"s"t"e"r"e"d" "r"e"a"l" "e"s"t"a"t"e" "i"n"v"e"s"t"m"e"n"t" "t"r"u"s"t" "t"h"a"t" "s"p"e"c"i"a"l"i"z"e"s" "i"n" "t"h"e" "i"n"v"e"s"t"m"e"n"t" "a"n"d" "o"w"n"e"r"s"h"i"p" "o"f" "u"p"p"e"r" "m"i"d"s"c"a"l"e" "a"n"d" "u"p"s"c"a"l"e"," "p"r"e"m"i"u"m"-"b"r"a"n"d"e"d"," "s"e"l"e"c"t"-"s"e"r"v"i"c"e"," "e"x"t"e"n"d"e"d"-"s"t"a"y"," "a"n"d" "l"i"m"i"t"e"d"-"s"e"r"v"i"c"e" "h"o"t"e"l"s" "i"n" "t"h"e" "t"o"p" "1"0"0" "M"e"t"r"o"p"o"l"i"t"a"n" "S"t"a"t"i"s"t"i"c"a"l" "A"r"e"a"s" "(""?"M"S"A"s""?")" "w"i"t"h" "a" "p"a"r"t"i"c"u"l"a"r" "f"o"c"u"s" "o"n" "t"h"e" "t"o"p" "2"0" "t"o" "6"0" "M"S"A"s"." "T"h"e" "C"o"m"p"a"n"y" "c"u"r"r"e"n"t"l"y" "o"w"n"s" "1"5" "h"o"t"e"l"s" "i"n" "8" "s"t"a"t"e"s"." "C"o"n"d"o"r"'"s" "h"o"t"e"l"s" "a"r"e" "f"r"a"n"c"h"i"s"e"d" "b"y" "a" "n"u"m"b"e"r" "o"f" "t"h"e" "i"n"d"u"s"t"r"y"'"s" "m"o"s"t" "w"e"l"l"-"r"e"g"a"r"d"e"d" "b"r"a"n"d" "f"a"m"i"l"i"e"s" "i"n"c"l"u"d"i"n"g" "H"i"l"t"o"n"," "M"a"r"r"i"o"t"t"," "a"n"d" "I"n"t"e"r"C"o"n"t"i"n"e"n"t"a"l" "H"o"t"e"l"s"."
Full CDOR Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.